SPONSORED CONTENT Consider the following scenario: A recent change in electronic health record billing at one of your outpatient clinics […]
SPONSORED CONTENT Let’s be honest. 340B compliance is demanding. It takes time, coordination, and precision. After more than a decade […]
SPONSORED CONTENT The 340B program is facing a period of unprecedented change. With the Inflation Reduction Act (IRA) and Medicare’s […]
SPONSORED CONTENT When it comes to doing more with less, Community Health Centers (CHCs) and Federally Qualified Health Centers (FQHCs) […]
SPONSORED CONTENT Drug manufacturers defend their unrelenting campaign to reform the 340B program by citing, among other things, the need […]
SPONSORED CONTENT The 340B program has been bombarded with threats over the past five years. 340B professionals have had their hands […]
SPONSORED CONTENT Whether it’s new manufacturer restrictions affecting script and data qualification, amended state laws or regulations, or updated audit […]
SPONSORED CONTENT The U.S. drug pricing infrastructure is entering a transformative era. On August 1, 2025, the Health Resources and […]
SPONSORED CONTENT Federally Qualified Health Centers (FQHCs) play a critical role in delivering accessible and affordable healthcare to underserved communities. […]
SPONSORED CONTENT The 340B program has morphed into a battlefield of rules, audits, and reporting. For smaller covered entities (CEs), […]